Cargando…
Sirolimus as frontline therapy for PTEN-mutated histiocytic sarcoma
Autores principales: | Chohan, Karan L., Abeykoon, Jithma P., Young, Jason R., Tobin, W. Oliver, Koster, Mathew J., Shah, Mithun V., Ryu, Jay H., Vassallo, Robert, Rech, Karen L., Ravindran, Aishwarya, Goyal, Gaurav, Go, Ronald S., Bennani, N. Nora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230420/ https://www.ncbi.nlm.nih.gov/pubmed/36475523 http://dx.doi.org/10.3324/haematol.2022.282207 |
Ejemplares similares
-
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience
por: Goyal, Gaurav, et al.
Publicado: (2022) -
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders
por: Zanwar, Saurabh, et al.
Publicado: (2022) -
P1049: CHARACTERISTICS AND OUTCOMES OF CARDIOVASCULAR INVOLVEMENT IN ERDHEIM-CHESTER DISEASE
por: Tawfiq, Reema, et al.
Publicado: (2023) -
Prolonged remission with pembrolizumab and radiation therapy in a patient with multisystem Langerhans cell sarcoma
por: Zanwar, Saurabh, et al.
Publicado: (2022) -
Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis
por: Hu, Marie, et al.
Publicado: (2022)